99mTc-fanolesomab Palatin Technologies

Charito Love, Christopher J. Palestro

Research output: Contribution to journalReview article

23 Scopus citations

Abstract

99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis.

Original languageEnglish (US)
Pages (from-to)1079-1085
Number of pages7
JournalIDrugs
Volume6
Issue number11
Publication statusPublished - Nov 1 2003
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Love, C., & Palestro, C. J. (2003). 99mTc-fanolesomab Palatin Technologies. IDrugs, 6(11), 1079-1085.